Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP567096.RAg-_4p-zhSQ6hVb-mnF3VSBnOooVean4Yw6C6umrYCVg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP567096.RAg-_4p-zhSQ6hVb-mnF3VSBnOooVean4Yw6C6umrYCVg130_assertion type Assertion NP567096.RAg-_4p-zhSQ6hVb-mnF3VSBnOooVean4Yw6C6umrYCVg130_head.
- NP567096.RAg-_4p-zhSQ6hVb-mnF3VSBnOooVean4Yw6C6umrYCVg130_assertion description "[This is the first study showing the beneficial effect of combining 17-AAG and ritonavir and our data suggest that HSF-1 may be a novel therapeutic target in the treatment of renal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567096.RAg-_4p-zhSQ6hVb-mnF3VSBnOooVean4Yw6C6umrYCVg130_provenance.
- NP567096.RAg-_4p-zhSQ6hVb-mnF3VSBnOooVean4Yw6C6umrYCVg130_assertion evidence source_evidence_literature NP567096.RAg-_4p-zhSQ6hVb-mnF3VSBnOooVean4Yw6C6umrYCVg130_provenance.
- NP567096.RAg-_4p-zhSQ6hVb-mnF3VSBnOooVean4Yw6C6umrYCVg130_assertion SIO_000772 22470109 NP567096.RAg-_4p-zhSQ6hVb-mnF3VSBnOooVean4Yw6C6umrYCVg130_provenance.
- NP567096.RAg-_4p-zhSQ6hVb-mnF3VSBnOooVean4Yw6C6umrYCVg130_assertion wasDerivedFrom befree-20150227 NP567096.RAg-_4p-zhSQ6hVb-mnF3VSBnOooVean4Yw6C6umrYCVg130_provenance.
- NP567096.RAg-_4p-zhSQ6hVb-mnF3VSBnOooVean4Yw6C6umrYCVg130_assertion wasGeneratedBy ECO_0000203 NP567096.RAg-_4p-zhSQ6hVb-mnF3VSBnOooVean4Yw6C6umrYCVg130_provenance.